Global Gene Therapy on Neurological Diseases Market Research Report 2023
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
According to QYResearch’s new survey, global Gene Therapy on Neurological Diseases market is projected to reach US$ 12190 million in 2029, increasing from US$ 4347 million in 2022, with the CAGR of 16.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gene Therapy on Neurological Diseases market research.
The Drug Based on Gene Therapy market is primarily driven by the revolutionary potential of gene therapy to address genetic disorders at their root cause, offering a new paradigm for treating previously incurable conditions. Gene therapy involves introducing genetic material into a patient's cells to correct or replace faulty genes, aiming to restore normal cellular function. The increasing understanding of the genetic basis of diseases, coupled with advancements in gene delivery methods and genome editing techniques, contributes to market growth. Moreover, the demonstrated benefits of gene therapy in providing targeted and long-lasting treatments, overcoming limitations of traditional pharmacological approaches, and offering hope to patients with rare genetic disorders further propel adoption. However, challenges include optimizing gene delivery efficiency, addressing potential immune responses, and ensuring the long-term safety and durability of gene-based treatments. Navigating regulatory pathways, conducting rigorous clinical trials, and addressing ethical considerations are ongoing concerns. The market's success relies on continuous research in genetic medicine, collaborations between biotechnology companies and research institutions, and comprehensive education on the benefits and potential challenges of using gene therapy-based drugs while addressing the evolving challenges associated with precision medicine and personalized treatments.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gene Therapy on Neurological Diseases market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Gene Therapy on Neurological Diseases market is projected to reach US$ 12190 million in 2029, increasing from US$ 4347 million in 2022, with the CAGR of 16.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gene Therapy on Neurological Diseases market research.
The Drug Based on Gene Therapy market is primarily driven by the revolutionary potential of gene therapy to address genetic disorders at their root cause, offering a new paradigm for treating previously incurable conditions. Gene therapy involves introducing genetic material into a patient's cells to correct or replace faulty genes, aiming to restore normal cellular function. The increasing understanding of the genetic basis of diseases, coupled with advancements in gene delivery methods and genome editing techniques, contributes to market growth. Moreover, the demonstrated benefits of gene therapy in providing targeted and long-lasting treatments, overcoming limitations of traditional pharmacological approaches, and offering hope to patients with rare genetic disorders further propel adoption. However, challenges include optimizing gene delivery efficiency, addressing potential immune responses, and ensuring the long-term safety and durability of gene-based treatments. Navigating regulatory pathways, conducting rigorous clinical trials, and addressing ethical considerations are ongoing concerns. The market's success relies on continuous research in genetic medicine, collaborations between biotechnology companies and research institutions, and comprehensive education on the benefits and potential challenges of using gene therapy-based drugs while addressing the evolving challenges associated with precision medicine and personalized treatments.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gene Therapy on Neurological Diseases market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Biogen
- Novartis
- Sarepta Therapeutics
- Viral Gene Therapy
- Non-viral Gene Therapy
- Hospital
- Clinic
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Viral Gene Therapy
1.2.3 Non-viral Gene Therapy
1.3 Market by Application
1.3.1 Global Gene Therapy on Neurological Diseases Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Gene Therapy on Neurological Diseases Market Perspective (2018-2029)
2.2 Gene Therapy on Neurological Diseases Growth Trends by Region
2.2.1 Global Gene Therapy on Neurological Diseases Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Therapy on Neurological Diseases Historic Market Size by Region (2018-2023)
2.2.3 Gene Therapy on Neurological Diseases Forecasted Market Size by Region (2024-2029)
2.3 Gene Therapy on Neurological Diseases Market Dynamics
2.3.1 Gene Therapy on Neurological Diseases Industry Trends
2.3.2 Gene Therapy on Neurological Diseases Market Drivers
2.3.3 Gene Therapy on Neurological Diseases Market Challenges
2.3.4 Gene Therapy on Neurological Diseases Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Gene Therapy on Neurological Diseases Players by Revenue
3.1.1 Global Top Gene Therapy on Neurological Diseases Players by Revenue (2018-2023)
3.1.2 Global Gene Therapy on Neurological Diseases Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy on Neurological Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy on Neurological Diseases Revenue
3.4 Global Gene Therapy on Neurological Diseases Market Concentration Ratio
3.4.1 Global Gene Therapy on Neurological Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy on Neurological Diseases Revenue in 2022
3.5 Gene Therapy on Neurological Diseases Key Players Head office and Area Served
3.6 Key Players Gene Therapy on Neurological Diseases Product Solution and Service
3.7 Date of Enter into Gene Therapy on Neurological Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GENE THERAPY ON NEUROLOGICAL DISEASES BREAKDOWN DATA BY TYPE
4.1 Global Gene Therapy on Neurological Diseases Historic Market Size by Type (2018-2023)
4.2 Global Gene Therapy on Neurological Diseases Forecasted Market Size by Type (2024-2029)
5 GENE THERAPY ON NEUROLOGICAL DISEASES BREAKDOWN DATA BY APPLICATION
5.1 Global Gene Therapy on Neurological Diseases Historic Market Size by Application (2018-2023)
5.2 Global Gene Therapy on Neurological Diseases Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Gene Therapy on Neurological Diseases Market Size (2018-2029)
6.2 North America Gene Therapy on Neurological Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gene Therapy on Neurological Diseases Market Size by Country (2018-2023)
6.4 North America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Gene Therapy on Neurological Diseases Market Size (2018-2029)
7.2 Europe Gene Therapy on Neurological Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gene Therapy on Neurological Diseases Market Size by Country (2018-2023)
7.4 Europe Gene Therapy on Neurological Diseases Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Gene Therapy on Neurological Diseases Market Size (2018-2029)
8.2 Asia-Pacific Gene Therapy on Neurological Diseases Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2018-2023)
8.4 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Gene Therapy on Neurological Diseases Market Size (2018-2029)
9.2 Latin America Gene Therapy on Neurological Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gene Therapy on Neurological Diseases Market Size by Country (2018-2023)
9.4 Latin America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Gene Therapy on Neurological Diseases Market Size (2018-2029)
10.2 Middle East & Africa Gene Therapy on Neurological Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2018-2023)
10.4 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Therapy on Neurological Diseases Introduction
11.1.4 Biogen Revenue in Gene Therapy on Neurological Diseases Business (2018-2023)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Therapy on Neurological Diseases Introduction
11.2.4 Novartis Revenue in Gene Therapy on Neurological Diseases Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Sarepta Therapeutics
11.3.1 Sarepta Therapeutics Company Detail
11.3.2 Sarepta Therapeutics Business Overview
11.3.3 Sarepta Therapeutics Gene Therapy on Neurological Diseases Introduction
11.3.4 Sarepta Therapeutics Revenue in Gene Therapy on Neurological Diseases Business (2018-2023)
11.3.5 Sarepta Therapeutics Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Viral Gene Therapy
1.2.3 Non-viral Gene Therapy
1.3 Market by Application
1.3.1 Global Gene Therapy on Neurological Diseases Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Gene Therapy on Neurological Diseases Market Perspective (2018-2029)
2.2 Gene Therapy on Neurological Diseases Growth Trends by Region
2.2.1 Global Gene Therapy on Neurological Diseases Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Therapy on Neurological Diseases Historic Market Size by Region (2018-2023)
2.2.3 Gene Therapy on Neurological Diseases Forecasted Market Size by Region (2024-2029)
2.3 Gene Therapy on Neurological Diseases Market Dynamics
2.3.1 Gene Therapy on Neurological Diseases Industry Trends
2.3.2 Gene Therapy on Neurological Diseases Market Drivers
2.3.3 Gene Therapy on Neurological Diseases Market Challenges
2.3.4 Gene Therapy on Neurological Diseases Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Gene Therapy on Neurological Diseases Players by Revenue
3.1.1 Global Top Gene Therapy on Neurological Diseases Players by Revenue (2018-2023)
3.1.2 Global Gene Therapy on Neurological Diseases Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy on Neurological Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy on Neurological Diseases Revenue
3.4 Global Gene Therapy on Neurological Diseases Market Concentration Ratio
3.4.1 Global Gene Therapy on Neurological Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy on Neurological Diseases Revenue in 2022
3.5 Gene Therapy on Neurological Diseases Key Players Head office and Area Served
3.6 Key Players Gene Therapy on Neurological Diseases Product Solution and Service
3.7 Date of Enter into Gene Therapy on Neurological Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GENE THERAPY ON NEUROLOGICAL DISEASES BREAKDOWN DATA BY TYPE
4.1 Global Gene Therapy on Neurological Diseases Historic Market Size by Type (2018-2023)
4.2 Global Gene Therapy on Neurological Diseases Forecasted Market Size by Type (2024-2029)
5 GENE THERAPY ON NEUROLOGICAL DISEASES BREAKDOWN DATA BY APPLICATION
5.1 Global Gene Therapy on Neurological Diseases Historic Market Size by Application (2018-2023)
5.2 Global Gene Therapy on Neurological Diseases Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Gene Therapy on Neurological Diseases Market Size (2018-2029)
6.2 North America Gene Therapy on Neurological Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gene Therapy on Neurological Diseases Market Size by Country (2018-2023)
6.4 North America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Gene Therapy on Neurological Diseases Market Size (2018-2029)
7.2 Europe Gene Therapy on Neurological Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gene Therapy on Neurological Diseases Market Size by Country (2018-2023)
7.4 Europe Gene Therapy on Neurological Diseases Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Gene Therapy on Neurological Diseases Market Size (2018-2029)
8.2 Asia-Pacific Gene Therapy on Neurological Diseases Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2018-2023)
8.4 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Gene Therapy on Neurological Diseases Market Size (2018-2029)
9.2 Latin America Gene Therapy on Neurological Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gene Therapy on Neurological Diseases Market Size by Country (2018-2023)
9.4 Latin America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Gene Therapy on Neurological Diseases Market Size (2018-2029)
10.2 Middle East & Africa Gene Therapy on Neurological Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2018-2023)
10.4 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Therapy on Neurological Diseases Introduction
11.1.4 Biogen Revenue in Gene Therapy on Neurological Diseases Business (2018-2023)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Therapy on Neurological Diseases Introduction
11.2.4 Novartis Revenue in Gene Therapy on Neurological Diseases Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Sarepta Therapeutics
11.3.1 Sarepta Therapeutics Company Detail
11.3.2 Sarepta Therapeutics Business Overview
11.3.3 Sarepta Therapeutics Gene Therapy on Neurological Diseases Introduction
11.3.4 Sarepta Therapeutics Revenue in Gene Therapy on Neurological Diseases Business (2018-2023)
11.3.5 Sarepta Therapeutics Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Viral Gene Therapy
Table 3. Key Players of Non-viral Gene Therapy
Table 4. Global Gene Therapy on Neurological Diseases Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Gene Therapy on Neurological Diseases Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gene Therapy on Neurological Diseases Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Gene Therapy on Neurological Diseases Market Share by Region (2018-2023)
Table 8. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gene Therapy on Neurological Diseases Market Share by Region (2024-2029)
Table 10. Gene Therapy on Neurological Diseases Market Trends
Table 11. Gene Therapy on Neurological Diseases Market Drivers
Table 12. Gene Therapy on Neurological Diseases Market Challenges
Table 13. Gene Therapy on Neurological Diseases Market Restraints
Table 14. Global Gene Therapy on Neurological Diseases Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Gene Therapy on Neurological Diseases Market Share by Players (2018-2023)
Table 16. Global Top Gene Therapy on Neurological Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy on Neurological Diseases as of 2022)
Table 17. Ranking of Global Top Gene Therapy on Neurological Diseases Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Gene Therapy on Neurological Diseases Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene Therapy on Neurological Diseases Product Solution and Service
Table 21. Date of Enter into Gene Therapy on Neurological Diseases Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy on Neurological Diseases Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2018-2023)
Table 25. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2024-2029)
Table 27. Global Gene Therapy on Neurological Diseases Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Gene Therapy on Neurological Diseases Revenue Market Share by Application (2018-2023)
Table 29. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gene Therapy on Neurological Diseases Revenue Market Share by Application (2024-2029)
Table 31. North America Gene Therapy on Neurological Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Gene Therapy on Neurological Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Gene Therapy on Neurological Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Gene Therapy on Neurological Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Gene Therapy on Neurological Diseases Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gene Therapy on Neurological Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Gene Therapy on Neurological Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 46. Biogen Company Detail
Table 47. Biogen Business Overview
Table 48. Biogen Gene Therapy on Neurological Diseases Product
Table 49. Biogen Revenue in Gene Therapy on Neurological Diseases Business (2018-2023) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Gene Therapy on Neurological Diseases Product
Table 54. Novartis Revenue in Gene Therapy on Neurological Diseases Business (2018-2023) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Sarepta Therapeutics Company Detail
Table 57. Sarepta Therapeutics Business Overview
Table 58. Sarepta Therapeutics Gene Therapy on Neurological Diseases Product
Table 59. Sarepta Therapeutics Revenue in Gene Therapy on Neurological Diseases Business (2018-2023) & (US$ Million)
Table 60. Sarepta Therapeutics Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
Table 1. Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Viral Gene Therapy
Table 3. Key Players of Non-viral Gene Therapy
Table 4. Global Gene Therapy on Neurological Diseases Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Gene Therapy on Neurological Diseases Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gene Therapy on Neurological Diseases Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Gene Therapy on Neurological Diseases Market Share by Region (2018-2023)
Table 8. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gene Therapy on Neurological Diseases Market Share by Region (2024-2029)
Table 10. Gene Therapy on Neurological Diseases Market Trends
Table 11. Gene Therapy on Neurological Diseases Market Drivers
Table 12. Gene Therapy on Neurological Diseases Market Challenges
Table 13. Gene Therapy on Neurological Diseases Market Restraints
Table 14. Global Gene Therapy on Neurological Diseases Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Gene Therapy on Neurological Diseases Market Share by Players (2018-2023)
Table 16. Global Top Gene Therapy on Neurological Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy on Neurological Diseases as of 2022)
Table 17. Ranking of Global Top Gene Therapy on Neurological Diseases Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Gene Therapy on Neurological Diseases Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene Therapy on Neurological Diseases Product Solution and Service
Table 21. Date of Enter into Gene Therapy on Neurological Diseases Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy on Neurological Diseases Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2018-2023)
Table 25. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2024-2029)
Table 27. Global Gene Therapy on Neurological Diseases Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Gene Therapy on Neurological Diseases Revenue Market Share by Application (2018-2023)
Table 29. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gene Therapy on Neurological Diseases Revenue Market Share by Application (2024-2029)
Table 31. North America Gene Therapy on Neurological Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Gene Therapy on Neurological Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Gene Therapy on Neurological Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Gene Therapy on Neurological Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Gene Therapy on Neurological Diseases Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gene Therapy on Neurological Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Gene Therapy on Neurological Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 46. Biogen Company Detail
Table 47. Biogen Business Overview
Table 48. Biogen Gene Therapy on Neurological Diseases Product
Table 49. Biogen Revenue in Gene Therapy on Neurological Diseases Business (2018-2023) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Gene Therapy on Neurological Diseases Product
Table 54. Novartis Revenue in Gene Therapy on Neurological Diseases Business (2018-2023) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Sarepta Therapeutics Company Detail
Table 57. Sarepta Therapeutics Business Overview
Table 58. Sarepta Therapeutics Gene Therapy on Neurological Diseases Product
Table 59. Sarepta Therapeutics Revenue in Gene Therapy on Neurological Diseases Business (2018-2023) & (US$ Million)
Table 60. Sarepta Therapeutics Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Gene Therapy on Neurological Diseases Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Gene Therapy on Neurological Diseases Market Share by Type: 2022 VS 2029
Figure 3. Viral Gene Therapy Features
Figure 4. Non-viral Gene Therapy Features
Figure 5. Global Gene Therapy on Neurological Diseases Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Gene Therapy on Neurological Diseases Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Gene Therapy on Neurological Diseases Report Years Considered
Figure 11. Global Gene Therapy on Neurological Diseases Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Gene Therapy on Neurological Diseases Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Gene Therapy on Neurological Diseases Market Share by Region: 2022 VS 2029
Figure 14. Global Gene Therapy on Neurological Diseases Market Share by Players in 2022
Figure 15. Global Top Gene Therapy on Neurological Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy on Neurological Diseases as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy on Neurological Diseases Revenue in 2022
Figure 17. North America Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)
Figure 19. United States Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)
Figure 23. Germany Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Gene Therapy on Neurological Diseases Market Share by Region (2018-2029)
Figure 31. China Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)
Figure 39. Mexico Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)
Figure 43. Turkey Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Biogen Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2018-2023)
Figure 46. Novartis Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2018-2023)
Figure 47. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2018-2023)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Figure 1. Global Gene Therapy on Neurological Diseases Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Gene Therapy on Neurological Diseases Market Share by Type: 2022 VS 2029
Figure 3. Viral Gene Therapy Features
Figure 4. Non-viral Gene Therapy Features
Figure 5. Global Gene Therapy on Neurological Diseases Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Gene Therapy on Neurological Diseases Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Gene Therapy on Neurological Diseases Report Years Considered
Figure 11. Global Gene Therapy on Neurological Diseases Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Gene Therapy on Neurological Diseases Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Gene Therapy on Neurological Diseases Market Share by Region: 2022 VS 2029
Figure 14. Global Gene Therapy on Neurological Diseases Market Share by Players in 2022
Figure 15. Global Top Gene Therapy on Neurological Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy on Neurological Diseases as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy on Neurological Diseases Revenue in 2022
Figure 17. North America Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)
Figure 19. United States Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)
Figure 23. Germany Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Gene Therapy on Neurological Diseases Market Share by Region (2018-2029)
Figure 31. China Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)
Figure 39. Mexico Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)
Figure 43. Turkey Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Biogen Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2018-2023)
Figure 46. Novartis Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2018-2023)
Figure 47. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2018-2023)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
